(DES) WisdomTree U.S. SmallCap - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717W6049 • Small Value

DES: Small Cap, Dividend, Stocks, Index, ETF

The WisdomTree U.S. SmallCap Dividend Fund (NYSE ARCA:DES) is designed to track the performance of small-capitalization dividend-paying companies in the U.S. Under normal market conditions, the fund invests at least 95% of its total assets in securities that replicate the economic characteristics of its underlying index. This includes holding constituent securities of the index and other investments with similar economic traits. The funds underlying index is fundamentally weighted, focusing on small-cap firms that generate dividends, providing exposure to both income and growth potential in the small-cap segment.

As a non-diversified fund, it may concentrate its holdings in a smaller number of securities compared to diversified funds. This approach allows for targeted exposure to small-cap dividend payers, which are often characterized by stable cash flows and established business models. The funds methodology emphasizes dividend-paying companies, which historically have demonstrated lower volatility and resilience during market downturns compared to non-dividend payers.

Based on the provided data, here is a 3-month forecast:

From a technical perspective, the fund is currently trading below its 20-day and 50-day moving averages, with the 20-day SMA at 29.63 and the 50-day SMA at 31.40. The 200-day SMA of 33.38 indicates a bearish trend in the medium term. The ATR of 0.92 suggests moderate volatility. If the fund fails to reclaim its 50-day SMA, it may face further downside pressure, potentially testing the 28.50-29.00 range. Conversely, a breakout above the 50-day SMA could signal a reversal, with resistance at 32.00-33.00.

From a fundamental perspective, the funds AUM of $1.7 billion reflects its liquidity and investor confidence. Small-cap dividend payers are likely to remain attractive in a low-yield environment, supported by their ability to generate consistent income. However, broader market conditions, including interest rate changes and economic growth trends, will play a significant role in shaping the funds performance over the next quarter.

Additional Sources for DES ETF

DES ETF Overview

Market Cap in USD 1,717m
Category Small Value
TER 0.38%
IPO / Inception 2006-06-16

DES ETF Ratings

Growth Rating 56.6
Fundamental -
Dividend Rating 54.8
Rel. Strength -11
Analysts -
Fair Price Momentum 27.26 USD
Fair Price DCF -

DES Dividends

Dividend Yield 12m 2.81%
Yield on Cost 5y 5.28%
Annual Growth 5y 5.73%
Payout Consistency 94.8%

DES Growth Ratios

Growth Correlation 3m -90.8%
Growth Correlation 12m 24.2%
Growth Correlation 5y 71.8%
CAGR 5y 12.32%
CAGR/Max DD 5y 0.49
Sharpe Ratio 12m -0.35
Alpha -10.88
Beta 0.829
Volatility 18.03%
Current Volume 146.5k
Average Volume 20d 175.3k
What is the price of DES stocks?
As of May 02, 2025, the stock is trading at USD 30.19 with a total of 146,545 shares traded.
Over the past week, the price has changed by -0.02%, over one month by -5.51%, over three months by -10.90% and over the past year by +0.65%.
Is WisdomTree U.S. SmallCap a good stock to buy?
Partly, yes. Based on ValueRay Analyses, WisdomTree U.S. SmallCap (NYSE ARCA:DES) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.55 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DES as of May 2025 is 27.26. This means that DES is currently overvalued and has a potential downside of -9.71%.
Is DES a buy, sell or hold?
WisdomTree U.S. SmallCap has no consensus analysts rating.
What are the forecast for DES stock price target?
According to ValueRays Forecast Model, DES WisdomTree U.S. SmallCap will be worth about 31.2 in May 2026. The stock is currently trading at 30.19. This means that the stock has a potential upside of +3.31%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31.2 3.3%